Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Panbela Therapeutics Q3 EPS $(0.16) Beats $(0.23) Estimate

Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.23) by 30.43 percent. This is a 23.81 percent increase over losses of $(0.21) per share
byBenzinga Newsdesk
November 10, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.23) by 30.43 percent. This is a 23.81 percent increase over losses of $(0.21) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Solar Capital’s Earnings: A Preview

By Benzinga Insights
Today, 4:28 PM
Solar Capital (NASDAQ:SLRC) is set to give its latest quarterly earnings report on Wednesday, 2021-11-03. Here's what investors need to know before the announcement. Analysts estimate that Solar Capital will likely report an Earnings Per Share (EPS) of $0.37

SLRC